APSR2026-945

 
Late-Breaking
Submitted
Oral Presentation
AO32-005
 
 
 
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Yanan Zhou * Fudan University Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University Shanghai China
Ying Wang - Fudan University Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University Shanghai China
Yuanlin Song - Fudan University Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University Shanghai China
-
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
Yanan
Zhou
zyn_zhou@163.com
+8613661705209
Under 30
China
Original Research
Lower respiratory tract Rothia as a protective factor against adverse outcomes in pneumonia: A multicenter prospective cohort study with multi-omics analysis
Maximum 25 words
Abstract Content
To identify risk factors for 28-day mortality in pneumonia patients, and to explore the potential mechanisms of Rothia.
This multicenter prospective cohort study enrolled patients from 13 hospitals in Shanghai, China. Baseline characteristics and bronchoalveolar lavage fluid specimens were collected. 16S rRNA sequencing was performed on a subset of specimens, followed by metagenomic next-generation sequencing (mNGS) in all patients. Integrated proteomic, transcriptomic, and metabolomic analyses were conducted to explore underlying mechanisms. Key findings were validated in a C57BL/6J mouse model of Pseudomonas aeruginosa (PAO1) infection.
A total of 529 patients were included, of whom 75 (14.18%) died within 28 days. 16S rRNA sequencing revealed lower Rothia abundance in pneumonia patients. mNGS analysis showed that the Rothia-positive (Rothia+) group exhibited significantly higher alpha diversity, increased abundance of Prevotella, Parvimonas, Streptococcus and Veillonella, and decreased abundance of Corynebacterium, Elizabethkingia, and Simplexvirus. Correlation analysis revealed a positive association between Rothia and Streptococcus, and a negative association with Corynebacterium. Multivariable analysis confirmed Rothia+ as an independent protective factor for both 28-day mortality (HR: 0.54; 95%CI: 0.32-0.91) and invasive mechanical ventilation (IMV) (OR: 0.55; 95%CI: 0.32-0.93). Multi-omics analysis revealed that, the Rothia+ group exhibited downregulation of MMP9, SF3B2, creatine, and taurine, and upregulation of CST1, AMY1B, SLC1A5, and pentadecanal. These molecules were enriched in pathways including salivary secretion, leukocyte transendothelial migration, neutrophil extracellular trap formation, and histidine metabolism. Although no overlapping pathways, correlation analysis revealed that MMP9, ARHGAP25, and 6-oxopiperidine-2-carboxylic acid were negatively correlated with Rothia abundance. In vivo experiments showed that Rothia alone induced mild pulmonary inflammation, but significantly ameliorated PAO1-induced lung injury and systemic bacterial burden in co-infected mice.
Rothia may serve as an independent protective factor against 28-day mortality in pneumonia patients, potentially through modulation of host immune-metabolic pathways and microbial interactions that suppress excessive inflammation.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Rothia; Pneumonia; Multi-omics
maximum 3 keywords and no abbreviations, separated by commas
 
304